Medizinische Universität Graz Austria/Österreich - Forschungsportal - Medical University of Graz

Logo MUG-Forschungsportal

Gewählte Publikation:

SHR Neuro Krebs Kardio Lipid

Richtig, G; Cerroni, L; Schmidt, H; Beham-Schmid, C; Deinlein, T; Vallant, C; Richtig, E.
Talimogene laherparepvec can initiate plasma cell invasion into infiltrated melanoma lesions - a case series.
J Eur Acad Dermatol Venereol. 2020;
PubMed FullText FullText_MUG

 

Autor/innen der Med Uni Graz:
Beham-Schmid Christine
Cerroni Lorenzo
Deinlein Teresa Maria
Richtig Erika
Richtig Georg
Schmidt Helmut
Vallant Christina Martha
Altmetrics:

Dimensions Citations:

Plum Analytics:

Scite (citation analytics):

Abstract:
Talimogene laherparepvec (T-VEC) is a genetically engineered herpes simplex virus type 1 (HSV-1) and used in locally advanced melanoma patients. Its mode of action is not fully understood. We present three cases where T-VEC caused monoclonal as well as polyclonal B-cell infiltration. This article is protected by copyright. All rights reserved.

© Med Uni Graz Impressum